TURKEY of the YEAR
Nov. 22, 2017
Greetings!

Happy Thanksgiving week, friends -- each time the calendar turns to late November, we start to look at the teasers of the past twelve months... all with a mind to naming the year's Turkey, the ugliest stock tout of the year.  So what is the "Turkey of the Year" for 2017?  I won't keep you in suspense much longer, just click below to...

Miss anything last week?

It was another wild week of macro gyrations, fantastic earnings, and crazy hype-filled newsletter promises... so what caught the eye of your favorite Gumshoe?  The most-discussed teaser pick was Stansberry Venture's "radical treatment that could treat 1 in 2 of all cancer patients" ... who owns the patent on that treatment, and will this breakthrough start rewarding investors on December 31?  Thinkolator answers here.

We started out the week with a look at the "Dividend Superstations" being teased by Brett Owens at Contrarian Income Report... can you really get dividends from those Tesla charging stations?  My musings are here.

And Doc Gumshoe chimed in with an update on what's happening with Alzheimer's Disease and Dementia -- that spurred a lot of discussion, comments and suggestions from readers, you can check it out here.

And speaking of Tesla, Marin Katusa started teasing us about how to profit from "Elon Musk's Next Disruption" ... which ended up being a spiel about his 'secret' copper stocks, you can see the Thinkolator's answers to that teaser here.

I closed things out with the Friday File for our Irregulars, and you can catch that here if you missed the email -- no big transactions in the Real Money Portfolio this week, but I update some thoughts on Chinese retailers, copper, and a few other things that are driving returns.  That piece is here.

Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

If you wish to unsubscribe to these mailings, there are links at both the bottom and top of this email that you can use to do so permanently and safely, we have no wish to email people who don't want to receive these messages. Please note that unsubscribing using the link below applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.
Stock Gumshoe, 351 Pleasant St., Suite B #205, Northampton, MA 01060
Sent by travis@stockgumshoe.com in collaboration with
Constant Contact